Pinpointing the Top Questions about Biosimilars in Rheumatology
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Jennifer I. Lim, MD, FARVO
Carl Regillo, MD
The Multiple Faces of ATTRv-PN
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
Shh…Gene-Silencing Therapies for ATTRv-PN
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
John Berk, MD
Loading...
We’re glad to see you’re enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.